Perioperative glucose control: living in uncertain times—Continuing Professional Development

Girard, Martin; Schricker, Thomas

doi:10.1007/s12630-010-9449-3

Cited by 15 publications

(30 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This term refers to the hyperglycemia in surgical patients who are known to be non-diabetic (2). Hyperglycemia due to surgical stress is a result of a couple of metabolic changes in glucose utilization including release of counter-regulatory hormones and pro-inflammatory cytokines.…”

Section: Perioperative Hyperglycemia Vs Diabetes Mellitusmentioning

confidence: 99%

Perioperative Control of Blood Glucose

Kuşkonmaz

Arslan

2015

Med Sci and Discov

View full text Add to dashboard Cite

This review mainly focuses on the management of type 2 diabetes in the preoperative setting with a special emphasis on intraoperative glycemic control. Some patients learn their diagnosis of diabetes just prior to the surgery. The prevalence of previously undiagnosed diabetes is reported to be 5.2-10% in literature. Treatment protocols must be tailored individually but evidence based approach in insulin administration and close monitoring of blood glucose are important in order to avoid both hyper and hypoglycemia

show abstract

Section: Perioperative Hyperglycemia Vs Diabetes Mellitusmentioning

confidence: 99%

Perioperative Control of Blood Glucose

Kuşkonmaz

Arslan

2015

Med Sci and Discov

View full text Add to dashboard Cite

show abstract

“…Auch eine intraoperative Blutzuckereinstellung auf Normalwerte unter 140 mg/dl kann die perioperative Morbidität und Mortalität erhöhen [14]. Obwohl es bisher keine klar definierten Zielwerte gibt, wird empfohlen, den Blutzuckerspiegel bei großen chirurgischen Eingriffen unter 10 mmol/l (180 mg/dl) zu halten [14,18,27,33].…”

Section: Diabetes-medikation ▼unclassified

Perioperatives Medikamentenmanagement

Gschiel

Fritsch²,

Böck³

2012

Dtsch med Wochenschr

View full text Add to dashboard Cite

The management of chronic medication in the perioperative phase represents as a serious challenge for the involved physicians. Especially patients with elevated ASA-scores frequently suffer from multiple co-morbidities which often need numerous medications. The probability of pharmacological interactions rises with the number of these medications. Moreover it must be taken into consideration that chronic medication potentially interferes with both intravenous and inhaled anesthetics and moreover, bleeding complications are more likely to occur in patients undergoing chronic pharmacotherapy. The aim of this article is to provide a summary of the existing evidence concerning perioperative medication in patients undergoing non-cardiac surgery. Several guidelines and advisories dealing with cardiovascular medication have been published during the last decade. The main scope of these publications was on beta-blockers and other cardiovascular medication. There is less evidence on not-cardiovascular medication as in most cases only case reports and expert opinions are published. Existing epidemiologic studies on this topic are rather heterogeneous.

show abstract

“…11 Moreover, concerns have arisen regarding the high incidence of hypoglycemia in association with intensive glucose control [8][9][10]12 and the possibility that hypoglycemia may offset its potential benefits. 11 Despite these reservations, however, tight glucose control may be beneficial for some populations 11,13,14 and clearly requires additional study. 11,15,16 In this sub-study, we reported on the validation of our insulin infusion algorithm in terms of time to achieve target, percent of time spent within desired range, incidence of severe and moderate hypoglycemia, and glucose variability.…”

Section: Résumémentioning

confidence: 99%